angioimmunoblastic t cell lymphoma

Showing 1 - 3 of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T Cell Lymphoma, ALK-negative Anaplastic Large Cell

Unknown status
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • +5 more
  • CEOP/IVE/GDP chemotherapy regimen
  • CEOP chemotherapy regimen for 6 cycles
  • Fuzhou, Fujian, China
  • +3 more
Mar 7, 2020

ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified, Angioimmunoblastic T Cell

Unknown status
  • ALK-negative Anaplastic Large Cell Lymphoma
  • +5 more
  • Cyclophosphamide 750mg/m2
  • +8 more
  • Shanghai, Shanghai, China
    Ruijin hospital
Nov 10, 2017

Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma Trial

Completed
  • Peripheral T Cell Lymphoma Unspecified
  • +3 more
  • RAD001 (Everolimus)
  • Goyang-si, Kyoungki-do, Korea, Republic of
  • +4 more
Mar 1, 2015